Artificial Intelligence (AI) in Life Sciences Market Research Report 2024-2029 Featuring AiCure, Apixio, Atomwise, Benevolentai, Enlitic, Numedii, Recursion, & Zebra Technologies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Oct 8, 2024--

The "Artificial Intelligence (AI) in Life Sciences Market" report has been added to ResearchAndMarkets.com's offering.

The global market for artificial intelligence (AI) in life sciences was $8 billion in 2023. Mass spectrometry technology innovation and biomarker development are helping the market grow, and it is expected to reach $33.5 billion by the end of 2029. The market is forecast to grow at a CAGR of 27.9% from 2024 through 2029.

The report includes an in-depth analysis of trends in the global AI market for life sciences, covering market revenue data from 2021 to 2023, with estimates for 2024 and projected CAGRs through 2029. It provides detailed estimates of the current market size and revenue prospects, and a comprehensive market share analysis based on product segment, application, end user, and region.

Key aspects of the report include facts and figures related to market dynamics, current and emerging technologies, and the regulatory landscape, along with the expected impact of macroeconomic factors on the industry. It identifies AI products and technologies with the highest commercial potential, focusing on their applications in life sciences, particularly in precision medicine and personalized healthcare.

The report also highlights ESG developments and sustainability trends, emphasizing consumer attitudes, companies' ESG score rankings, and ESG practices. Additionally, it reviews patent activity and key patent grants relevant to AI in life sciences.

An analysis of the industry structure is provided, covering companies' market shares, merger and acquisition activity, and the outlook for venture funding. The report profiles leading companies in the field, such as AiCure LLC, Apixio Inc., Atomwise Inc., BenevolentAI, and NuMedii Inc.

Key Highlights:

• By product, software had the highest share of 65.6% in 2023, and this segment is expected to achieve a CAGR of 30.4% over the forecast period.
• By application, the clinical and molecular diagnostics segment had the highest share of 28.9% in 2023. This segment is expected to grow at a CAGR of 27.6% during the forecast period.
• By end user, the contract research organization segment had the highest share of 64.5% in 2023. This segment is expected to grow at a CAGR of 29.2% during the forecast period.
• In terms of market share, North America was the largest worldwide region in 2023, followed by Europe, Asia-Pacific, and the rest of the world. The North American market is projected to grow at a CAGR of 28.1% over the forecast period.

Company Profiles

• AiCure
• Apixio
• Atomwise Inc.
• Benevolentai
• Enlitic Inc.
• Numedii Inc.
• Recursion
• Zebra Technologies Corp.

Key Attributes:

Key Topics Covered:

Chapter 1: Executive Summary

• Outlook
• Scope of Report
• Market Summary

Chapter 2: Market Overview

• Artificial Intelligence in Drug Discovery
• Intelligence in Molecular Diagnostics
• Artificial Intelligence in Clinical Diagnostics
• Artificial Intelligence in Clinical Trials
• Artificial Intelligence in Precision Medicine

Chapter 3: Market Dynamics

• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges

Chapter 4: Emerging Technologies and Developments

• Clinical Trials
• Clinical Trials, by Status
• Clinical Trials, by Study
• Granted Patents

Chapter 5: Market Segmentation Analysis

Market Analysis, by Product

• Global
• Software
• Services

Market Analysis, by Application

• Drug Discovery
• Clinical and Molecular Diagnostics
• Clinical Trials
• Precision and Personalized Medicine

Market Analysis, by End User

• Market Analysis and Forecast
• Contract Research Organizations
• Research Centers and Academic Institutes
• Pharmaceutical and Biotechnology Companies

Market Analysis, by Region

Chapter 6: Competitive Intelligence

• Top Players and Products
• Strategic Analysis
• Mergers and Acquisitions
• Funding

For more information about this report visit https://www.researchandmarkets.com/r/htourv

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20241008730739/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: TECHNOLOGY HEALTH TECHNOLOGY HEALTH ARTIFICIAL INTELLIGENCE

SOURCE: Research and Markets

Copyright Business Wire 2024.